Search results
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 2 days agoHims & Hers announced that it will now be selling a compounded version of popular diabetes and...
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- In just a few years, Hims & Hers Health Inc. reached almost $1 billion in sales by...
Hims & Hers Stock Spikes 27%
Barrons.com· 5 days agoThe telehealth company Hims & Hers Health said it is offering weight-loss injections with the same active ingredient as Wegovy and Ozempic for as low as...
Hims & Hers Now Selling Off-Brand Ozempic, Wegovy for $199
Healthline· 3 days agoHims & Hers is now selling compounded semaglutide for weight loss. Compounded medications undergo...
Hims & Hers health PAO Irene Becklund sells $13,673 in stock By Investing.com
Investing.com· 5 days agoHims & Hers Health, Inc. (NYSE:HIMS) reported a significant transaction by PAO Irene Becklund,...
Soleil Boughton Sells 4,915 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock
ETF DAILY NEWS· 3 days agoHims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Soleil Boughton sold 4,915 shares of the company’s stock in a transaction dated Monday, May ...
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Bloomberg· 5 days agoHave a confidential tip for our reporters? In just a few years, Hims & Hers Health Inc. reached...
Hims & Hers Health says it will offer compounded GLP-1 injections
AOL· 5 days agoDigital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The company, which offers a range ...
Hims & Hers Health Stock Jumps Nearly 28% on Plans to Offer GLP-1 Weight-Loss Drugs
Investopedia· 6 days agoShares of Hims & Hers Health (HIMS) surged close to 28% Monday after the telehealth company said it...
Traders Buy High Volume of Call Options on Hims & Hers Health (NYSE:HIMS)
ETF DAILY NEWS· 4 days agoHims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Stock traders acquired 51,395 ...